G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan
· Delayed Price · Currency is TWD 35.15
+0.20 (0.57%)
Apr 29, 2026, 1:30 PM CST
G&E Herbal Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 78.41 | 152.59 | 139.68 | 114.75 | 12.28 | Upgrade
|
| Short-Term Investments | 351.9 | 256.29 | 173.24 | 91.2 | 96.6 | Upgrade
|
| Cash & Short-Term Investments | 430.31 | 408.87 | 312.92 | 205.95 | 108.88 | Upgrade
|
| Cash Growth | 5.24% | 30.66% | 51.94% | 89.15% | -9.31% | Upgrade
|
| Accounts Receivable | 17.06 | 17.8 | 14.78 | 0.75 | 5.09 | Upgrade
|
| Other Receivables | 0.24 | 0.16 | 0.15 | 0.02 | 0.03 | Upgrade
|
| Receivables | 17.31 | 17.96 | 14.93 | 0.77 | 5.12 | Upgrade
|
| Inventory | 25.3 | 21.71 | 22.9 | 24.64 | 19.83 | Upgrade
|
| Prepaid Expenses | 1.78 | 2.38 | 1.41 | 1.32 | 2.07 | Upgrade
|
| Total Current Assets | 474.69 | 450.92 | 352.17 | 232.69 | 135.9 | Upgrade
|
| Property, Plant & Equipment | 366.04 | 372.31 | 375.12 | 375.15 | 382.85 | Upgrade
|
| Other Intangible Assets | 132.73 | 133.33 | 133.89 | 134.68 | 135.51 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.35 | 0.26 | 19.65 | 37.95 | 37.59 | Upgrade
|
| Other Long-Term Assets | 1.42 | 2.37 | 2.27 | 2.31 | 0.28 | Upgrade
|
| Total Assets | 975.22 | 959.17 | 883.1 | 782.78 | 692.13 | Upgrade
|
| Accounts Payable | 7.53 | 8.34 | 4.03 | 8.97 | 2.73 | Upgrade
|
| Accrued Expenses | 15.48 | 17.72 | 17.34 | 8.11 | 1.64 | Upgrade
|
| Current Portion of Leases | 0.78 | 0.88 | 0.69 | - | - | Upgrade
|
| Current Income Taxes Payable | 15.62 | 3.1 | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.13 | 85.23 | 95.24 | 71.85 | 0.45 | Upgrade
|
| Other Current Liabilities | 7.52 | 9.51 | 1.28 | 2.82 | 3.85 | Upgrade
|
| Total Current Liabilities | 47.05 | 124.77 | 118.57 | 91.74 | 8.68 | Upgrade
|
| Long-Term Leases | 0.09 | 0.87 | 1.29 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.2 | - | Upgrade
|
| Total Liabilities | 47.15 | 125.64 | 119.86 | 91.94 | 8.68 | Upgrade
|
| Common Stock | 637.2 | 590 | 556.6 | 556.6 | 556.6 | Upgrade
|
| Additional Paid-In Capital | 134.24 | 134.24 | 134.24 | 273.33 | 273.33 | Upgrade
|
| Retained Earnings | 156.64 | 109.3 | 72.4 | -139.09 | -146.47 | Upgrade
|
| Shareholders' Equity | 928.07 | 833.53 | 763.24 | 690.84 | 683.45 | Upgrade
|
| Total Liabilities & Equity | 975.22 | 959.17 | 883.1 | 782.78 | 692.13 | Upgrade
|
| Total Debt | 0.87 | 1.75 | 1.98 | - | - | Upgrade
|
| Net Cash (Debt) | 429.44 | 407.13 | 310.94 | 205.95 | 108.88 | Upgrade
|
| Net Cash Growth | 5.48% | 30.93% | 50.98% | 89.15% | -9.31% | Upgrade
|
| Net Cash Per Share | 6.72 | 6.38 | 4.88 | 3.23 | 1.71 | Upgrade
|
| Filing Date Shares Outstanding | 63.72 | 63.72 | 63.72 | 63.72 | 63.72 | Upgrade
|
| Total Common Shares Outstanding | 63.72 | 63.72 | 63.72 | 63.72 | 63.72 | Upgrade
|
| Working Capital | 427.64 | 326.14 | 233.6 | 140.95 | 127.22 | Upgrade
|
| Book Value Per Share | 14.56 | 13.08 | 11.98 | 10.84 | 10.73 | Upgrade
|
| Tangible Book Value | 795.34 | 700.21 | 629.34 | 556.16 | 547.95 | Upgrade
|
| Tangible Book Value Per Share | 12.48 | 10.99 | 9.88 | 8.73 | 8.60 | Upgrade
|
| Land | 148.59 | 148.59 | 148.59 | 148.59 | 148.59 | Upgrade
|
| Buildings | 233.86 | 233.58 | 233.58 | 233.08 | 233.39 | Upgrade
|
| Machinery | 49.5 | 50.77 | 52.08 | 55.06 | 55.32 | Upgrade
|
| Construction In Progress | 2.59 | 2.39 | - | - | - | Upgrade
|
| Leasehold Improvements | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.